Literature DB >> 3577477

Susceptibility of the black-legged tick, Ixodes scapularis, to the Lyme disease spirochete, Borrelia burgdorferi.

W Burgdorfer, K L Gage.   

Abstract

Experiments to determine whether Ixodes scapularis can be infected with the Lyme disease agent, Borrelia burgdorferi, demonstrated that infection and transstadial transmission occurs in up to 73% of larval ticks that had fed on spirochetemic rabbits. In a limited number of nymphal ticks examined, the spirochetes were found only in the midgut. Feeding nymphal I. scapularis on a normal rabbit resulted in blood infection characterized by two distinct periods of spirochetemia, suggesting the occurrence of a relapse phenomenon similar to that in tick-borne relapsing fevers. This was also indicated by the percentage of infected ticks recovered daily during the experiment. Accordingly, ticks fed during low spirochetemias or negative blood phase, showed low infection rates or were not infected whereas those fed during peak spirochetemias had high infection rates. Of 11 adult I. scapularis examined to date, 6 were infected but the spirochetes were restricted to the midgut. These preliminary findings establish the susceptibility of I. scapularis to B. burgdorferi and the potential role of this tick as an efficient vector of the Lyme disease spirochete.

Entities:  

Mesh:

Year:  1986        PMID: 3577477     DOI: 10.1016/s0176-6724(86)80096-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  15 in total

1.  A Rickettsia genome overrun by mobile genetic elements provides insight into the acquisition of genes characteristic of an obligate intracellular lifestyle.

Authors:  Joseph J Gillespie; Vinita Joardar; Kelly P Williams; Timothy Driscoll; Jessica B Hostetler; Eric Nordberg; Maulik Shukla; Brian Walenz; Catherine A Hill; Vishvanath M Nene; Abdu F Azad; Bruno W Sobral; Elisabet Caler
Journal:  J Bacteriol       Date:  2011-11-04       Impact factor: 3.490

Review 2.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

3.  Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi).

Authors:  T G Schwan; K K Kime; M E Schrumpf; J E Coe; W J Simpson
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 4.  Transmission of Lyme disease spirochetes (Borrelia burgdorferi).

Authors:  J Piesman
Journal:  Exp Appl Acarol       Date:  1989-06       Impact factor: 2.132

5.  Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi.

Authors:  V G Bundoc; A G Barbour
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Investigation of the validity of species status of Ixodes dammini (Acari: Ixodidae) using rDNA.

Authors:  D M Wesson; D K McLain; J H Oliver; J Piesman; F H Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Isolation and transmission of the Lyme disease spirochete from the southeastern United States.

Authors:  J H Oliver; F W Chandler; M P Luttrell; A M James; D E Stallknecht; B S McGuire; H J Hutcheson; G A Cummins; R S Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  Colony formation and morphology in Borrelia burgdorferi.

Authors:  T J Kurtti; U G Munderloh; R C Johnson; G G Ahlstrand
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

9.  Co-circulating microorganisms in questing Ixodes scapularis nymphs in Maryland.

Authors:  Katherine I Swanson; Douglas E Norris
Journal:  J Vector Ecol       Date:  2007-12       Impact factor: 1.671

10.  Relative utilization of reptiles and rodents as hosts by immature Ixodes scapularis (Acari: Ixodidae) in the coastal plain of North Carolina, USA.

Authors:  C S Apperson; J F Levine; T L Evans; A Braswell; J Heller
Journal:  Exp Appl Acarol       Date:  1993-10       Impact factor: 2.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.